• Abecma 260-500 x 10e6 cells dispersion for infusion

  Form: solution for injection

  Active substance	Dosage
  IDECABTAGEN VICLEUCEL	260–500 × 10e6 CELULAS

  ATC: L01X L01XL L01XL07

• Abraxane 5 mg/ml powder for dispersion for infusion

  Form: powder for preparation of infusion solution

  Active substance	Dosage
  PACLITAXEL	100 mg

  ATC: L01C L01CD L01CD01

• Baraclude 0.5 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  ENTECVIR	0,5 mg

  ATC: J05A J05AF J05AF10

• Baraclude 1 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  ENTECVIR	1 mg

  ATC: J05A J05AF J05AF10

• Breyanzi 1.1-70 × 10E6 cells/mL / 1.1-70 × 10E6 cells/mL dispersion for infusion

  Form: solution for injection

  Active substance	Dosage
  LISOCABTAGEN MARALEUCEL	1,1-70 × 10e6 CELULAS

  ATC: L01X L01XL L01XL08

• Camzyos 10 mg hard capsules

  Form: capsules, hard

  Active substance	Dosage
  MAVACAMTEN	10 mg

  ATC: C01E C01EB C01EB24

• Camzyos 15 mg hard capsules

  Form: capsules, hard

  Active substance	Dosage
  MAVACAMTEN	15 mg

  ATC: C01E C01EB C01EB24

• Camzyos 2.5 mg hard capsules

  Form: capsules, hard

  Active substance	Dosage
  MAVACAMTEN	2,5 mg

  ATC: C01E C01EB C01EB24

• Camzyos 5 mg hard capsules

  Form: capsules, hard

  Active substance	Dosage
  MAVACAMTEN	5 mg

  ATC: C01E C01EB C01EB24

• EmpliCiti 400 mg powder for concentrate for solution for infusion

  Form: powder for concentrate for solution for infusion

  Active substance	Dosage
  ELOTUZUMAB	400 mg

  ATC: L01F L01FX L01FX08

• Evotaz 300 mg/150 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  ATAZANAVIR SULFATE	341,70 mg
  COBICISTAT	294,12 mg

  ATC: J05A J05AR J05AR15

• Imnovid 3 mg hard capsules

  Form: capsules, hard

  Active substance	Dosage
  POMALIDOMIDE	3 mg

  ATC: L04A L04AX L04AX06

• Imnovid 4 mg hard capsules

  Form: capsules, hard

  Active substance	Dosage
  POMALIDOMIDE	4 mg

  ATC: L04A L04AX L04AX06

• Inrebic 100 mg hard capsules

  Form: capsules, hard

  Active substance	Dosage
  Fedratinib dihydrochloride monohydrate	117,3 mg

  ATC: L01E L01EJ L01EJ02

• Nulojix 250 mg powder for concentrate for solution for infusion

  Form: powder for concentrate for solution for infusion

  Active substance	Dosage
  BELATACEPT	275 mg

  ATC: L04A L04AA L04AA28

• Onureg 200 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  AZACITIDINE	200 mg

  ATC: L01B L01BC L01BC07

• Onureg 300 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  AZACITIDINE	300 mg

  ATC: L01B L01BC L01BC07

• Opdivo 10 mg/ml concentrate for solution for infusion

  Form: solution for infusion, concentrate

  Active substance	Dosage
  NIVOLUMAB	47 mg/dosis

  ATC: L01F L01FF L01FF01

• Opdivo 10 mg/ml concentrate for solution for infusion

  Form: solution for infusion, concentrate

  Active substance	Dosage
  NIVOLUMAB	107 mg/dosis

  ATC: L01F L01FF L01FF01

• Orencia 125 mg solution for injection in pre-filled pen

  Form: solution for injection in pre-filled pen

  Active substance	Dosage
  ABATACEPT	125,875 mg

  ATC: L04A L04AA L04AA24

• Orencia 125 mg solution for injection in pre-filled syringe

  Form: solution for injection in a pre-filled syringe

  Active substance	Dosage
  ABATACEPT	125,875 mg

  ATC: L04A L04AA L04AA24

• Orencia 250 mg powder for concentrate for infusion solution

  Form: solution for infusion, concentrate

  Active substance	Dosage
  ABATACEPT	250 mg

  ATC: L04A L04AA L04AA24

• Reblozyl 25 mg powder for injection solution

  Form: powder for solution for injection

  Active substance	Dosage
  LUSPATERCEPT	25 mg

  ATC: B03X B03XA B03XA06

• Reblozyl 75 mg powder for solution for injection

  Form: powder for solution for injection

  Active substance	Dosage
  LUSPATERCEPT	75 mg

  ATC: B03X B03XA B03XA06

• Revlimid 10 mg hard capsules

  Form: capsules, hard

  Active substance	Dosage
  LENALIDOMIDE	10 mg

  ATC: L04A L04AX L04AX04

• Revlimid 15 mg hard capsules

  Form: capsules, hard

  Active substance	Dosage
  LENALIDOMIDE	15 mg

  ATC: L04A L04AX L04AX04

• Revlimid 20 mg hard capsules

  Form: capsules, hard

  Active substance	Dosage
  LENALIDOMIDE	20 mg

  ATC: L04A L04AX L04AX04

• Revlimid 25 mg hard capsules

  Form: capsules, hard

  Active substance	Dosage
  LENALIDOMIDE	15 mg

  ATC: L04A L04AX L04AX04

• Revlimid 5 mg hard capsules

  Form: capsules, hard

  Active substance	Dosage
  LENALIDOMIDE	5 mg

  ATC: L04A L04AX L04AX04

• Sotyktu 6 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  DEUCRAVACITINIB	6 mg

  ATC: L04A L04AF L04AF07

• Sprycel 20 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  DASATINIB MONOHYDRATE	20 mg

  ATC: L01E L01EA L01EA02

• Sprycel 50 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  DASATINIB MONOHYDRATE	50 mg

  ATC: L01E L01EA L01EA02

• Sprycel 70 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  DASATINIB MONOHYDRATE	70 mg

  ATC: L01E L01EA L01EA02

• Vidaza 25 mg/ml powder for injectable suspension

  Form: powder for injectable suspension

  Active substance	Dosage
  AZACITIDINE	25 mg

  ATC: L01B L01BC L01BC07

• Yervoy 5 mg/ml concentrate for solution for infusion

  Form: solution for infusion, concentrate

  Active substance	Dosage
  IPILIMUMAB	213 mg

  ATC: L01F L01FX L01FX04

• Yervoy 5 mg/ml concentrate for solution for infusion

  Form: solution for infusion, concentrate

  Active substance	Dosage
  IPILIMUMAB	53,5 mg

  ATC: L01F L01FX L01FX04

• Zeposia 0.23 mg/0.46 mg hard capsules

  Form: capsules, hard

  Active substance	Dosage
  OZANIMOD HYDROCHLORIDE	0.25 mg
  OZANIMOD HYDROCHLORIDE	0,5 mg

  ATC: L04A L04AE L04AE02

• Zeposia 0.92 mg hard capsules

  Form: capsules, hard

  Active substance	Dosage
  OZANIMOD HYDROCHLORIDE	1 mg

  ATC: L04A L04AE L04AE02